Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Low Dose Ketamine Infusion for Comorbid Posttraumatic Stress Disorder and Chronic Pain Patients

To see complete record on, please visit this link

Id: NCT04322968

Organisation Name: VA Ann Arbor Healthcare System

Overal Status: Completed

Start Date: January 9, 2018

Last Update: December 22, 2020

Lead Sponsor: VA Ann Arbor Healthcare System

Brief Summary: The purpose of the study is to investigate the effectiveness of low dose IV ketamine infusion in the treatment of patients with PTSD and comorbid chronic pain.

Hypothesis: A single ketamine infusion should be associated with significantly greater reduction in core PTSD symptom levels after the treatment and such an effect is not only due to its analgesic properties but also through unknown mechanism of action that maybe related to NMDA/AMPA receptor modulation.

  • PTSD
  • Chronic Pain

Total execution time in seconds: 0.45400905609131